Amrutanjan Health Care Ltd
NSE: AMRUTANJAN BSE: 590006
₹515.55
(0.48%)
Sat, 28 Mar 2026, 02:48 am
Market Cap15.01B
PE Ratio26.18
Dividend0.90
Health Technology
Pharmaceuticals: Other
24.5KAmrutanjan Health Care Analysis
dividend
- Dividends per share have increased over the past 10 years.
- Dividends paid are well covered by earnings (4x coverage).
- Dividends per share have been stable in the past 10 years.
- Amrutanjan Health Care's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Amrutanjan Health Care's dividend is below the markets top 25% of dividend payers in India (3.08%).
health
- Amrutanjan Health Care is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Amrutanjan Health Care is profitable, therefore cash runway is not a concern.
- Amrutanjan Health Care is profitable, therefore cash runway is not a concern.
- Amrutanjan Health Care has no debt, it does not need to be covered by operating cash flow.
- Amrutanjan Health Care has no debt, it does not need to be covered by short term assets.
- Amrutanjan Health Care's cash and other short term assets cover its long term commitments.
- Amrutanjan Health Care has no debt compared to 5 years ago when it was 4.1%.
- Amrutanjan Health Care has no debt, therefore coverage of interest payments is not a concern.
- Amrutanjan Health Care has no debt.
- High level of physical assets or inventory.
management
- The tenure for the Amrutanjan Health Care board of directors is about average.
- Sivalenka's remuneration is lower than average for companies of similar size in India.
- Sivalenka's compensation has been consistent with company performance over the past year, both up more than 20%.
misc
- Amrutanjan Health Care is not covered by any analysts.
- Amrutanjan Health Care has significant price volatility in the past 3 months.
past
- Amrutanjan Health Care's 1-year earnings growth exceeds its 5-year average (99.2% vs 10.6%)
- Amrutanjan Health Care's year on year earnings growth rate has been positive over the past 5 years.
- Amrutanjan Health Care used its assets more efficiently than the IN Pharmaceuticals industry average last year based on Return on Assets.
- Amrutanjan Health Care has improved its use of capital last year versus 3 years ago (Return on Capital Employed).
- Amrutanjan Health Care has efficiently used shareholders’ funds last year (Return on Equity greater than 20%).
- Amrutanjan Health Care's earnings growth has exceeded the IN Pharmaceuticals industry average in the past year (99.2% vs 22.7%).
value
- 590006 outperformed the Market in India which returned -14.5% over the past year.
- Amrutanjan Health Care's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
- Amrutanjan Health Care's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
- Amrutanjan Health Care is overvalued based on assets compared to the IN Pharmaceuticals industry average.
- Amrutanjan Health Care is overvalued based on earnings compared to the IN Pharmaceuticals industry average.
- Amrutanjan Health Care is overvalued based on earnings compared to the India market.
- 590006 underperformed the Pharmaceuticals industry which returned 26.7% over the past year.
- BSE:590006 is up 5.8% underperforming the Pharmaceuticals industry which returned 6.8% over the past month.
- BSE:590006 is up 5.8% underperforming the market in India which returned 8% over the past month.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800